These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31612498)

  • 1. miR-145 promotes miR-133b expression through c-myc and DNMT3A-mediated methylation in ovarian cancer cells.
    Li J; Zhang S; Zou Y; Wu L; Pei M; Jiang Y
    J Cell Physiol; 2020 May; 235(5):4291-4301. PubMed ID: 31612498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
    Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
    Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC and DNMT3A-mediated DNA methylation represses microRNA-200b in triple negative breast cancer.
    Pang Y; Liu J; Li X; Xiao G; Wang H; Yang G; Li Y; Tang SC; Qin S; Du N; Zhang H; Liu D; Sun X; Ren H
    J Cell Mol Med; 2018 Dec; 22(12):6262-6274. PubMed ID: 30324719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
    Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M2 Macrophage-Derived Exosomes Regulate miR-199a-3p Promoter Methylation Through the LINC00470-Mediated myc/DNMT3a Axis to Promote Breast Cancer Development.
    Ma D; Wu J; Chen C; Niu Y; Ji K; Xiao Y; Guan Q
    Biochem Genet; 2024 Jun; 62(3):2082-2099. PubMed ID: 37851210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Myc modulates glucose metabolism via regulation of miR-184/PKM2 pathway in clear-cell renal cell carcinoma.
    Huang J; Kong W; Zhang J; Chen Y; Xue W; Liu D; Huang Y
    Int J Oncol; 2016 Oct; 49(4):1569-75. PubMed ID: 27431728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-myc promotes miR-92a-2-5p transcription in rat ovarian granulosa cells after cadmium exposure.
    Sun Y; Zong C; Liu J; Zeng L; Li Q; Liu Z; Li Y; Zhu J; Li L; Zhang C; Zhang W
    Toxicol Appl Pharmacol; 2021 Jun; 421():115536. PubMed ID: 33865896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-negative feedback interaction between DNA methyltransferase 3A and microRNA-145 in the Warburg effect of ovarian cancer cells.
    Zhang S; Pei M; Li Z; Li H; Liu Y; Li J
    Cancer Sci; 2018 Sep; 109(9):2734-2745. PubMed ID: 29993160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The negative feedback between miR-143 and DNMT3A regulates cisplatin resistance in ovarian cancer.
    Han X; Liu D; Zhou Y; Wang L; Hou H; Chen H; Zhang L; Chen W; Li X; Zhao L
    Cell Biol Int; 2021 Jan; 45(1):227-237. PubMed ID: 33090550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
    Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
    Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of DNMT3a expression increases miR-182-induced apoptosis of ovarian cancer through caspase-3 and caspase-9-mediated apoptosis and DNA damage response.
    Lu W; Lu T; Wei X
    Oncol Rep; 2016 Dec; 36(6):3597-3604. PubMed ID: 27748882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells.
    Lu J; Wang L; Chen W; Wang Y; Zhen S; Chen H; Cheng J; Zhou Y; Li X; Zhao L
    Arch Biochem Biophys; 2019 Jan; 661():1-9. PubMed ID: 30365936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.
    Taniguchi K; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakagawa Y; Ito Y; Otsuki Y; Uno B; Uchiyama K; Akao Y
    Cancer Lett; 2015 Jul; 363(1):17-27. PubMed ID: 25818238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
    Wang X; Liang Z; Xu X; Li J; Zhu Y; Meng S; Li S; Wang S; Xie B; Ji A; Liu B; Zheng X; Xie L
    Cell Death Dis; 2016 Dec; 7(12):e2503. PubMed ID: 27906180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Double-Negative Feedback Interaction between MicroRNA-29b and DNMT3A/3B Contributes to Ovarian Cancer Progression.
    Teng Y; Zuo X; Hou M; Zhang Y; Li C; Luo W; Li X
    Cell Physiol Biochem; 2016; 39(6):2341-2352. PubMed ID: 27832631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation.
    Hervouet E; Vallette FM; Cartron PF
    Epigenetics; 2009 Oct; 4(7):487-99. PubMed ID: 19786833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel miR-206/hnRNPA1/PKM2 axis reshapes the Warburg effect to suppress colon cancer growth.
    Fu R; Yang P; Amin S; Li Z
    Biochem Biophys Res Commun; 2020 Oct; 531(4):465-471. PubMed ID: 32800545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-145 function as a cell growth repressor by directly targeting c-Myc in human ovarian cancer.
    Zhang W; Wang Q; Yu M; Wu N; Wang H
    Technol Cancer Res Treat; 2014 Apr; 13(2):161-8. PubMed ID: 23919393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
    Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
    Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.